Home Suda Pharmaceuticals Ltd (ASX: SUD)

Suda Pharmaceuticals Ltd (ASX: SUD)

    Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report

    Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report

    Drugs intake in the form of pills, capsules, and tablets are not the most efficient ways of taking medicine, because only about 25% of...

    SUDA Pharmaceuticals Reformulating Billion-Dollar Drugs for Oral Delivery

    Australia’s leading oro-mucosal drug delivery company, SUDA Pharmaceuticals Ltd (ASX: SUD) produces reliable oral sprays by using its proprietary OroMist® technology to redevelop the...

    SUDA Makes Speedy Progress with its Robust Product Pipeline

    SUDA Pharmaceuticals Ltd (ASX: SUD) is transforming the drug delivery technology to improve the lifestyle and health of the global community by offering innovative...

    SUDA’s Science Advisory Board Member, Dr Richard Franklin Joins as Project Director of Anagrelide...

    SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery company headquartered in Perth, focusses on developing low-risk oral sprays using its proprietary OroMist® oro-mucosal...

    SUDA welcomes Australian Government’s Initiatives to Foster Medical Marijuana Industry

    To increase the bioavailability of administered medications, Australian-headquartered SUDA Pharmaceuticals Ltd (ASX: SUD) is reformulating medications into an oral spray. The delivery of medications...
    SUDA Pharmaceuticals: Pharmacy And Pharmacology Journal Publishes Impressive ZolpiMistTM Clinical Study Results

    SUDA Pharmaceuticals: Pharmacy And Pharmacology Journal Publishes Impressive ZolpiMistTM Clinical Study Results

    SUDA Pharmaceuticals Ltd (ASX: SUD) is an oro-mucosal drug delivery company that is reformulating medication into an oral spray to improve the bioavailability of...

    SUDA’s June Quarterly Report Out On ASX; A Look At Its Business And Technology

    On 31 July 2019, SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery firm, has released its June quarterly updates on the ASX. SUDA...

    SUDA’s MD and CEO, Mr Stephen Carter Back on Board

    An oro-mucosal drug delivery company headquartered in Perth, SUDA Pharmaceuticals Ltd (ASX: SUD) uses its OroMist® technology for the development of low-risk oral sprays....

    SUDA Receives Patent For The Only Effective Medicine For Platelet Reduction, Anagrelide; Stock Soars...

    With the rise in cases of the deadly disease cancer creating havoc across the globe, it is the need of the hour for the...

    A look at SUDA Pharmaceuticals’ Product Portfolio

    Headquartered in Western Australia, SUDA Pharmaceuticals Ltd (ASX: SUD) is a drug-delivery pharmaceutical company that develops low-risk, innovative pharmaceuticals to improve the health and...

    Recent News